Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Los Angeles Times - August 14, 2006
His comments were, of course, ludicrously narrow-minded, if not bigoted. Nonetheless, such thinking remains all too common, even among experts whose decisions affect the lives of millions of people around the world. To this day, concern that people in Africa are incapable of following a strict AIDS drug regimen is one reason some experts maintain that we shouldn't increase the continent's access to HIV medicines more quickly.
A recent study published in the Journal of the American Medical Assn. proves it's time to end this nonsense once and for all.
The largest and most extensive review on the topic to date analyzed nearly 30,000 poor and HIV-infected patients in North America and sub-Saharan Africa. The results? Just 55% of North Americans take their medications as directed, and 77% of sub-Saharan Africans adhere to their regimens.
What this shows, researchers believe, is that people in poor countries may actually work harder to stay on their medications, realizing they have little or even no access to other medical care if they don't.
The number of Africans who have access to AIDS medications has increased in recent years. But four out of five infected people still can't get treatment, which is why another 2 million people in the region died of the disease last year.
For that number to decrease, major donor countries - especially the United States - will have to continue to significantly increase the amount of money they're spending to fight the disease. They also must help poor countries find a better way to manage and distribute the aid.
These are the issues the world needs to focus on when the subject turns to AIDS. To debate whether people who are given lifesaving medications are intelligent enough to know what is best for them is worse than pointless. It's insulting.
060814
LT060806
Copyright © 2006 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053. http://www.latimes.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .